Evidence map›Paper›PMID 40199904›Full record

ArticleNature communications2025

A glycosylated lipooctapeptide promotes uptake and growth of Mycobacterium abscessus in the host.

Louis David Leclercq, Vincent Le Moigne, Wassim Daher, Mélanie Cortes, Bertus Viljoen, Yara Tasrini, Xavier Trivelli, Hélène Lavanant, Isabelle Schmitz-Afonso, Nicolas Durand and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Genomic Characterization and Taxonomic Classification ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Louis David LeclercqUniversité Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France.ORCID http://orcid.org/0000-0002-2513-7295
Vincent Le Moigne *Université Paris-Saclay, UVSQ, Inserm, Infection et inflammation, Montigny-Le-Bretonneux, France.
Wassim Daher *Centre National de la Recherche Scientifique UMR9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0001-9026-5333
Mélanie CortesUniversité Paris-Saclay, UVSQ, Inserm, Infection et inflammation, Montigny-Le-Bretonneux, France.ORCID http://orcid.org/0009-0000-0059-5356
Bertus ViljoenCentre National de la Recherche Scientifique UMR9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France.
Yara TasriniCentre National de la Recherche Scientifique UMR9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France.ORCID http://orcid.org/0009-0004-6110-2614
Xavier TrivelliUniversité de Lille, CNRS, INRAE, Centrale Lille, Université d'Artois, FR 2638-IMEC-Institut Michel-Eugène Chevreul, Lille, France.ORCID http://orcid.org/0000-0001-6775-9650
Hélène LavanantNormandie Univ, Univ Rouen Normandie, CNRS, CARMeN UMR 6064 (ex-COBRA-LCMT), Rouen, France.ORCID http://orcid.org/0000-0002-2963-0327
Isabelle Schmitz-AfonsoNormandie Univ, Univ Rouen Normandie, CNRS, CARMeN UMR 6064 (ex-COBRA-LCMT), Rouen, France.ORCID http://orcid.org/0000-0003-0665-0074
Nicolas DurandUniversité Paris-Saclay, UVSQ, Inserm, Infection et inflammation, Montigny-Le-Bretonneux, France.ORCID http://orcid.org/0000-0002-3613-2609
Franck BietINRAE, UMR ISP 1282, Université de Tours, Nouzilly, France.ORCID http://orcid.org/0000-0001-8425-6158
Yann GuérardelUniversité Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France. yann.guerardel@univ-lille.fr.ORCID http://orcid.org/0000-0003-4967-9512
Laurent KremerCentre National de la Recherche Scientifique UMR9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France. laurent.kremer@irim.cnrs.fr.ORCID http://orcid.org/0000-0002-6604-4458
Jean-Louis HerrmannUniversité Paris-Saclay, UVSQ, Inserm, Infection et inflammation, Montigny-Le-Bretonneux, France. jean-louis.herrmann@aphp.fr.ORCID http://orcid.org/0000-0003-2347-6418

Funding

Agence Nationale de la Recherche (French National Research Agency) 19-CE15-0012-01; SUNLIVEFondation pour la Recherche Médicale (Foundation for Medical Research in France) Equipe FRM EQU202103012588
6 · The paper itself

Abstract

Pathogenic mycobacteria produce a wide array of lipids which participate in host cell interactions and virulence. While some of these are conserved across all mycobacteria, others, like glycopeptidolipids (GPL), are restricted to a few species. Mycobacterium abscessus, an emerging rapid-growing pathogen, transitions from a smooth to a virulent rough variant upon the loss of surface GPL. Here, we discovered that M. abscessus and phylogenetically-close species harbor a second GPL-related locus, comprising two adjacent non-ribosomal peptide synthetase genes, MAB_4690c and MAB_4691c. A MAB_4690c deletion mutant (ΔMAB_4690c) failed to produce a yet undescribed lipid, designated GL8P for glycosylated lipooctapeptide, sharing an acylated octapeptide core adorned by mono or di-O-rhamnosyl substituents. ΔMAB_4690c exhibited impaired uptake and survival in THP-1 cells and was attenuated in mice. Importantly, GL8P elicited a strong humoral response in patients infected with M. abscessus. These results highlight the role of GL8P in the pathophysiology of infection by rough M. abscessus and suggest its potential as a selective marker for M. abscessus infections.

Indexed as

GlycopeptidesMycobacterium abscessusMycobacterium Infections, NontuberculousAnimalsBacterial ProteinsFemaleGlycolipidsGlycosylationHumansMiceTHP-1 CellsVirulenceBacterial ProteinsGlycolipidsGlycopeptides

Identifiers

PMID40199904
PMCPMC11978893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.